Trofinetide offers the first targeted treatment for Rett syndrome, with a new, convenient powdered formulation aimed at significantly reducing adverse effects. Rett syndrome is a severe ...
Switching to donidalorsen led to a 67.6% reduction in monthly HAE attack rates over 1 year, with consistent benefit across prior prophylactic therapies. Most patients achieved or maintained ...
Dr Dawson is chief of Adolescent Medicine Services, Carl R Darnall Army Medical Center Pediatric Clinic, Fort Hood, Texas.
A high percentage of pediatric patients with PANS (86.3%) and those with idiopathic OCD and/or tic disorders (96.6%) exhibited abnormal laboratory findings, with no significant differences between the ...
A phase 3 trial shows that lebrikizumab improves skin clearance and itch in infants and children with moderate to severe atopic dermatitis. Eli Lilly and Company announced positive topline results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results